Back
Aquestive Therapeutics, Inc. 10K Form
Buy
54
AQST
Aquestive Therapeutics, Inc.
Last Price:
$6.45
Seasonality Move:
-26.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AQST News And Ratings
See the #1 stock for the next 7 days that we like better than AQST
AQST Financial Statistics
Sales & Book Value
| Annual Sales: | $57.6M |
|---|---|
| Cash Flow: | $-12.9M |
| Price / Cash Flow: | 21.16 |
| Annual Sales: | $-0.03 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.70320 |
|---|---|
| Net Income (TTM): | $-69M |
| Gross Margin: | $39.7M |
| Return on Equity: | 0% |
| Return on Assets: | -60.42% |
Aquestive Therapeutics, Inc. Earnings Forecast
Key Aquestive Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for AQST is 68.95%.
-
The Selling, General & Administrative Expenses for AQST have been equal to 87.18% of Gross Profit Margin.
-
The Research & Development expenses have been 35.23% of Revenue.
-
The Net Earning history of AQST is -76.68% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
Aquestive Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AQST |
| CUSIP: | 03843E |
| Website: | aquestive.com |
Debt
| Debt-to-Equity Ratio: | -31.36 |
|---|---|
| Current Ratio: | 5.93 |
| Quick Ratio: | 5.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AQST Technical Analysis vs Fundamental Analysis
Buy
54
Aquestive Therapeutics, Inc. (AQST)
is a Buy
Is Aquestive Therapeutics, Inc. a Buy or a Sell?
-
Aquestive Therapeutics, Inc. stock is rated a BuyThe current Aquestive Therapeutics, Inc. [AQST] share price is $6.44. The Score for AQST is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.